Navigation Links
ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008
Date:10/30/2008

- Conference Call to Be Held at 4:00 P.M. Eastern Time -

EXTON, Pa., Oct. 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) will host a conference call and live audio webcast at 4:00 p.m. Eastern Time on Wednesday, November 5, 2008 to discuss the commercialization plans and launch of Cinryze C1 Inhibitor (human), which has been recently approved by the U.S. Food and Drug Administration for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE.

The live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com. An audio archive will be available at the same address until November 20, 2008. To participate in the conference call, please dial (877) 366-0713 (domestic) and (302) 607-2000 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing infor
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
2. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
3. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
4. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
5. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
6. ViroPharma Provides Update on Vancocin(R)
7. ViroPharma Augments Senior Management
8. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
9. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
10. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
11. ViroPharma to Present at the UBS Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...SentinelleMedicalInc.,aleadingmanufacturerofMagnet...cientificInc.,aleadingproviderofsoftwareenablingte...ast4DAdvancedVisualizationsoftware. ,, Thisinno...entbasedmedicalimagingofferinginthemarket.CalgaryS...intaccess-requiringnosoftwaredownload,andrunsonany...
(Date:11/25/2009)...re/--TheBlackAIDSInstituterecentlyheldBoardofDirec... ,, ThenewBoardMembersareahighlydiversegroupofl...vernmenthealthprograms,editorial,andbusinessentrep...albackgroundsincludingbothheterosexualandgayBlackm...tingmultipleagegroups. ,, (Photo: http://www.ne...
(Date:11/25/2009)...tically significant survival benefit from adjuvant...(ER)-positive tumors had high levels of phosphoryl..., according to a brief communication published onl...ncer Institute . , Approximately 50% of breast c...studies have shown that ER-alpha S118-P is require...
(Date:11/25/2009)...rthritis, could help newly diagnosed diabetics, st...Day News) -- A drug commonly used to treat non-Hod...shows some promise in helping patients newly diagn...b (Rituxan), helped patients keep producing some o...estroyed some of their pancreatic beta cells, whic...
(Date:11/25/2009)...trouble with the H1N1 vaccine, , , WEDN...1 swine flu pandemic may be driving a recent spike... U.S. health official said Wednesday. , "We are...ions around the country," Dr. Anne Schuchat, direc...spiratory Diseases at the U.S. Centers for Disease...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...rch institution involved with the promotion and co...In an attempt to strengthen research potential in ...t has been proposed to offer stronger and attracti...performance appraisal board constituted to review ...
...he first promising news regarding the deadly bird ...tment (ANTSZ) has said that a prototype //of a vac...ective against birds. 'The effectiveness of ...s are positive this prototype will serve as a basi...
...g, visual spatial processing, memory, and cognitiv...m. Smoking is much more prevalent among alcoholics...eurocognitive effects of cigarette smoking in alco...the USA set out to determine whether smoking contr...
...t supply of deceased donor kidneys for transplanta...ving donor kidney transplants.// A recent pape...uses on the insufficient supply of transplantable ...gies at a single center. The purpose of this artic...
...cheli an Italian epidemiologist as done a systemat...Mumps, Measles and Rubella (MMR) vaccine.// The st...ccination and autism or bowel disease. As it is be... concluded that MMR shots are safe and effective. ...
...), characterized by progressive memory loss, decli...nts, has been a major threat to ageing population.... Letters, reviews the different strategies in drug...hich has stimulated the search for more efficient ...
Other Medicine News:Health News:Strategies To Boost Living Donor Kidney Transplants 2Health News:MMR Vaccination not linked to Autism 2
(Date:11/25/2009)...all/--Pharmasset,Inc.(Nasdaq: VRUS ),aclinicalstag...opingandcommercializingnoveldrugstotreatviralinfec...dSeptember30,2009.AtSeptember30,2009Pharmassetheld...stments. ,, PipelineUpdateand2009Highlights ,...ovember2009,anindependentDataMonitoringCommittee(D...
(Date:11/25/2009)...rstCall/--FormanyofthemillionsofhearingimpairedAme...earingloss ,theholidaysmaynotbeallthathappy,saysau...identofHearUSA(Amex: EAR ),oneofAmerica,slargesthe...linkedhearinglosstostress,frustration,andsocialiso...ingswithfamiliesandfriends,whenmanyofthosewithhear...
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...sMarketAnalysisandForecaststo2015 ,, http://w...Devices-Market-Analysis-and-Forecasts-to-2015.html...Forecaststo2015 ,, Summary ,, Thisreportis...tingtotheUSdentaldevicesmarket.Italsooffersdetaile...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2Mylans Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Compan 47541 1AARP to Host Cross Generational Life Festival in Chicago June 5 6 47538 1AARP to Host Cross Generational Life Festival in Chicago June 5 6 47538 2
...TON, Oct. 14 Paratek Pharmaceuticals, Inc. today,..., formerly PTK 0796, a,first-in-class aminomethylc...er presentation at the 48th Interscience Conferenc.... ICAAC will be held in Washington, D.C.,from Octo...he poster session at ICAAC:, Sunday, October 26...
... YORK, Oct. 14 The Michael J. Fox,Foundation for ... to five,research teams to speed development of ef...e and mood-related symptoms of Parkinson,s disease...e from problems with,executive function (the abili...ementia; depression, apathy and anxiety; and behav...
Other Medicine Technology:Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 2Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 3Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 4
... a uniquely intelligent system, offers speed and t...vel design. Up to 27 reservoirs and 1 drying stati...tailor your staining programs to meet the demands ...s loading; The DRS 2000 works by automatically pic...
Aerospray Hematology Slide Stainer/Cytocentrifuge
Cholesterol FS
Cholesterol Reagent
Medicine Products: